A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown
ChemBioChem · 2026
DOI: 10.1002/cbic.70533 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2026. Verfasst von Joanna E Parkes und 10 weiteren Autor:innen. Beteiligte Einrichtung: MRC Nucleic Acid Therapy Accelerator (NATA), Research Complex at Harwell (RCaH), Oxford, UK. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, Oligonucleotides, Antisense, Thiouridine. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, UK Medical Research Council.
Abstract (Originalsprache)
Gapmer antisense oligonucleotides (ASOs) represent a clinically validated therapeutic platform, with a 2′‐ O ‐methoxyethyl modification commonplace within the flanking regions. An alternative sugar modification, incorporation of 4′‐thioribose, has demonstrated enhanced nuclease resistance in siRNAs and aptamers, but incorporation of this motif into gapmer architectures remains underexplored. Herein, we report the synthesis of a 4′‐thiouridine phosphoramidite building block and its incorporation into gapmer ASOs targeting PTEN . Evaluation of sequences containing 4′‐thiouridine in the flanking regions (compared with 2′‐ O ‐methoxyethyl) and varying phosphorothioate linkage composition demonstrates that the modified gapmers maintain equivalent knockdown efficacy under transfection and gymnotic delivery. These findings indicate 4′‐thioribose as an alternative sugar modification for wider exploration within gapmer ASOs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MRC Nucleic Acid Therapy Accelerator (NATA), Research Complex at Harwell (RCaH), Oxford, UK.
- Manchester Institute of Biotechnology & Department of Chemistry, University of Manchester, Manchester, UK.
ORCID-Profile: Joanna E Parkes, Sritama Bose, Sarah L Lovelock, Peter L Oliver, Gavin J Miller
Förderung
- Medical Research Council
- UK Medical Research Council
Zitieren
APA
Parkes, J. E., Benckendorff, C. M. M., Malinowska, A. L., Roberts, J., Huynh, H. L., Bose, S., Cochard, L. M., Cheallaigh, A. N., Lovelock, S. L., Oliver, P. L., & Miller, G. J. (2026). A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown. ChemBioChem. https://doi.org/10.1002/cbic.70533
Vancouver
Parkes JE, Benckendorff CMM, Malinowska AL, Roberts J, Huynh HL, Bose S, et al. A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown. ChemBioChem. 2026. doi:10.1002/cbic.70533
BibTeX
@article{Parkes2026,
author = {Parkes, Joanna E and Benckendorff, Caecilie M M and Malinowska, Anna L and Roberts, Jacob and Huynh, Harley L and Bose, Sritama and Cochard, Loïc M and Cheallaigh, Aisling Ní and Lovelock, Sarah L and Oliver, Peter L and Miller, Gavin J},
title = {A 4′‐Thioribouridine Modification Mimics 2′‐ O ‐Methoxyethyl in ASO‐Like 20‐Mers Targeting PTEN Knockdown},
journal = {ChemBioChem},
year = {2026},
doi = {10.1002/cbic.70533}
}
EUVIMED